Featured
6920 Pointe Inverness Way, Suite 140
Fort Wayne, IN, 46804
2604073977
The FDA’s accelerated approval of GENGLYCOS™ (pariglasgene brecaparvovec-opnr), also known as DTX401, introduces the first FDA-approved treatment option for glycogen storage disease type Ia (GSDIa).